Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma [Phase 1]
Open-label, sequential-dose Phase 1 study of PA5108 Latanoprost FA SR ocular implant for mild-to-moderate open-angle glaucoma has completed.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China [Phase 4]
A Phase 4 clinical trial in China evaluating adverse events and changes in disease activity after implantation of the XEN45 Glaucoma Treatme…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Next Generation Rocklatan [Phase 2]
A Phase 2 study of the next generation Rocklatan for open angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma [Phase 4]
Clinical trial update describing a Phase 4 study of standalone iStent Infinite and iDose TR for moderate-to-severe open-angle glaucoma, with…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Caffeine Consumption in Glaucoma Patients and Healthy Subjects [NA]
A clinical trial update about studying the effects of caffeine consumption in glaucoma patients and healthy subjects, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Evaluating Home Testing Devices for the Management of Glaucoma [NA]
A clinical trial evaluating home testing devices for managing open-angle glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study [Phase 2, Phase 3]
A randomized Phase 2/3 clinical trial evaluating nicotinamide and pyruvate for primary open-angle glaucoma is currently active but not recru…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Electrical Stimulation for Vision Neuroenhancement in Glaucoma [NA]
Stanford University is conducting a trial to test electrical stimulation for vision neuroenhancement in glaucoma. The study is currently rec…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Diagnostic Innovations in Glaucoma Study
A recruiting clinical trial from the University of California, San Diego is exploring diagnostic innovations for primary open-angle glaucoma…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
A real-world interventional study examining clinical outcomes in open-angle glaucoma and other chronic eye diseases; the study is currently …
-
FDA approval · 2025-10-09FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for TRAVATAN Z (travoprost) submitted by Novartis Pharmaceuticals Corporation, resulting in chan…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Optimal Treatment Protocol for Selective Laser Trabeculoplasty [NA]
This clinical trial update describes the status of a study evaluating the optimal treatment protocol for selective laser trabeculoplasty in …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT [NA]
An ongoing randomized controlled trial compares direct versus conventional selective laser trabeculoplasty (SLT) for open-angle glaucoma. En…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients [Phase 4]
Phase 4 clinical trial update evaluating Lumify for effects on ocular redness, intraocular pressure, and eyelid position in glaucoma patient…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma [NA]
Clinical trial comparing VISCO360 to SLT in primary open-angle glaucoma was terminated. Results assessing safety and effectiveness have been…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Effect of Kron (Citicoline and Nicotinamide Oral Solution) on Patients With Open-angle Glaucoma [NA]
This clinical trial update reports the completed study evaluating Kron (citicoline and nicotinamide oral solution) for open-angle glaucoma.
-
FDA approval · 2025-09-22FDA Approved: BIMATOPROST — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for bimatoprost from Amneal Pharmaceuticals NY LLC, enabling a generic version of the ophthalmic thera…
-
FDA approval · 2025-09-18FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for ALPHAGAN P (brimonidine tartrate) from Allergan, Inc., regarding labeling changes. The product i…
-
FDA approval · 2025-09-18FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) submitted by Allergan, Inc.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
A clinical trial update indicating a study on glaucoma, visual field loss, and their relationship with life-space mobility in older adults i…
-
CLINICAL_TRIALS other · 2025-09-12Clinical Trial Update: Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma. [NA]
This clinical trial update notes that iSTAR Medical's MINIject implant trial for primary open-angle glaucoma is active but not currently rec…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Impact of Glaucoma and Visual Field Loss on Life Space
Clinical trial investigating how glaucoma and visual field loss affect life space, currently active but not recruiting.
-
FDA approval · 2025-09-09FDA Approved: ZOLYMBUS — Original Application (Thea Pharma Inc.)
FDA approved ZOLYMBUS (bimatoprost) from Thea Pharma Inc. under NDA217307 as an ocular hypotensive agent to lower intraocular pressure in ad…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial comparing NCX-470 to latanoprost in open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial updates for NCX 470 ophthalmic solution evaluating aqueous humor dynamics in open-angle glaucoma. The study s…